Aller au contenu
Montreal view

International presence

Six commercial subsidiaries, 35 countries

The Group is made up of eight sites in France and worldwide, complemented by a network of local distributors.

Our locations

The Group worldwide

The Dômes Pharma Group handles the design, development, manufacturing and commercialisation of its products in France, Europe and the United States. Over the years the Group has been built through the successive creation and acquisition of brands and companies, which are now organised to optimise their synergies.

  • 8

    Sites worldwide

  • 6

    Commercial subsidiaries

    France, United Kingdom, Germany, Spain, United States, Canada

  • 35

    Countries

    through our local distributors

  • 400

    Employees

OUR AMBITION

Paul THIOU - Director North America

Combining local roots with international ambition

“We want to be a major, independent player in animal health, proud of its international and multichannel ambitions.”

Our sites

Headquarters and subsidiaries

Discover the entities that make up the Dômes Pharma Group. From the historic headquarters to subsidiaries in different countries, each contributes to the Group’s momentum through its expertise, its teams and its local roots.

1947

Dômes Pharma France

Dômes Pharma France, led by Philippe Roynard, is a leading animal health player present across France. With its 95 employees, the subsidiary markets the Dômes Pharma (formerly TVM), Biocanina, Léro and Aspivenin brands to vets and pharmacies, through a network of nearly 60 sales representatives.

1991

Dômes Pharma Headquaters

Located in Pont-du-Château, in Auvergne (France), the Group’s head office brings together the support functions, with 120 employees who support the development and performance of all the subsidiaries.

1992

Dômes Pharma Lempdes Manufacturing Site

Based in Lempdes in Auvergne, our French plant, with 130 employees, specialises in the manufacture and packaging of animal health medicines, with recognised expertise in non-sterile solid and liquid forms. The site is run by Christophe Mantion, Group Industrial Director.

Learn more

2016

Dômes Pharma UK

Based in Kirtlington, Oxfordshire, Dômes Pharma UK markets the Group’s animal health solutions in the United Kingdom. The subsidiary is led by Jonathan Hill and relies on a dedicated team of 21 employees to support British veterinary professionals.

2021

Dômes Pharma Germany

Based in Berlin, Dômes Pharma Germany, led by Peggy Behr, markets the Group’s animal health solutions with a local team of 15 employees.

2022

Dômes Pharma US

Based in Salt Lake City, Utah (United States), Dômes Pharma Inc. marks a key step in the Group’s international development. After first entering the US market in 2022, the acquisition of Dômes Pharma Inc. in 2023 brought in recognised expertise in veterinary ophthalmology, based on the exclusive BioHAnce™ technology. The site has its own 2,000 m² manufacturing plant, including 160 m² of ISO 7 clean rooms and 131 m² dedicated to sterile liquid production. The subsidiary has 30 employees and is led by Paul Thiou, Director North America.

2023

Dômes Pharma Iberia

Based in Madrid, Dômes Pharma Iberia markets the Group’s animal health products in the Spanish market. Led by Dr Ana Morcate, the subsidiary relies on a dedicated team of 11 employees to support veterinary professionals across the country.

2026

Dômes Pharma Canada

Dômes Pharma Canada, based in Montreal, illustrates the Group’s determination to continue its growth in North America. Led by Isabelle Renaud, the subsidiary relies on a team of 4 women to support Canadian vets with innovative solutions dedicated to companion animal health.

OUR TEAMS

The women and men behind Dômes Pharma

Beyond sites and locations, it is the talents, expertise and career paths that bring the Group to life every day.